RECEIVABLES

3 Months Ended

Mar. 31, 2019

Accounts Receivable, Net [Abstract]

Receivables [Text Block]

RECEIVABLES

Dollars in Millions	March 31, 2019			December 31, 2018
Trade receivables	$	4,873		$	4,914
Less charge-backs and cash discounts	(241		)	(245		)
Less bad debt allowances	(38		)	(33		)
Net trade receivables	4,594			4,636
Prepaid and refundable income taxes	158			218
Alliance, royalties, VAT and other	952			1,111
Receivables	$	5,704		$	5,965

Non-U.S. receivables sold on a nonrecourse basis were $174 million and $203 million for the three months ended March 31, 2019 and 2018, respectively. Receivables from the Company's three largest pharmaceutical wholesalers in the U.S. represented 70% of total trade receivables at March 31, 2019 and December 31, 2018.